Pegasus Development AG: Pegasus Present Its New Brand Pegastril - Nuevo
The coronavirus pandemic harbours the potential for enormous growth in specific industries. To that end, however, it's important to identify which markets will be dominant in the future.
One of the key growth sectors is the production and distribution of disinfectants and associated technologies. Regardless of whether a cure for, or vaccine against, COVID-19 is developed, protection against viruses and bacteria has become incredibly important across the globe and will continue to be a concern going forward.
This was one of the reasons why Pegasus Development AG decided to partner with the British disinfectant manufacturer Nuevo. One of the decisive factors choosing Nuevo was its highly competitive product, which is free from alcohol, animal products, perfume, essential oils or dyes. Furthermore, the product has already been tested according to the highest stipulations of the European standard EN 1276, is manufactured according to the latest regulations of the European Biocides Directive and has already been approved by the civil aviation authority.
Pegasus Development AG intends to make further inroads into this market, through the partnership with Nuevo and the newly created Pegastril-Nuevo brand www.pegastrilnuevo.ch .
The Swiss holding company is not limiting itself just to production and distribution, but offering integrated solutions in the form of spray systems and disinfection systems. The Swiss holding company has already started production and, together with international technology companies, has secured patents.
A number of orders for "human disinfection" devices have not only been received but are already being delivered. In addition to government inquiries from the Middle East and Africa, several European banks have expressed interest in this technology for their branch networks.
Thanks in particular to the patents acquired, Pegasus Development AG plans to become one of the most important global players, helping to shape the market. Profits generated through the sale of technology licenses represent a milestone at Pegasus Development AG and should give the company the decisive advantage required, not only to assert itself against the competition, but to play a central role in the industry in the long term.
About Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
CA-ANDERSEN-GLOBAL4.7.2020 14:56:13 CEST | Pressemeddelelse
Andersen Global udvider i Caribien
ALLEGRO-DVT3.7.2020 12:48:13 CEST | Press release
Ingenic Semiconductor Integrates Allegro DVT Encoding IP into Next-Generation Smart-Video System-On-Chip Solutions
PROVIDENCE-STRATEGIC3.7.2020 11:18:09 CEST | Press release
Imaweb-IDF Group Completes Its Acquisition of Serinfer
CENTRAL-NEWS-AGENCY3.7.2020 10:54:06 CEST | Press release
Taiwan’s COVID-19 response win applause, friendship from around the world
NORTHERN-DATA-AG3.7.2020 08:29:12 CEST | Press release
Northern Data announces new Block.one backed customer
VIIV-HEALTHCARE2.7.2020 22:41:09 CEST | Press release
ViiV Healthcare Announces US FDA Approval for Rukobia (fostemsavir), a First-in-Class Treatment for HIV in Adults With Few Treatment Options Available
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.Visit our pressroom